Baxter International (NYSE:BAX – Free Report) had its target price raised by Citigroup from $41.00 to $44.00 in a report published on Wednesday morning, Benzinga reports. Citigroup currently has a neutral rating on the medical instruments supplier’s stock. Several other brokerages have also recently issued reports on BAX. Barclays raised their target price on Baxter […]
Shares of Baxter International Inc. (NYSE:BAX – Get Free Report) have been assigned a consensus recommendation of “Hold” from the ten brokerages that are covering the stock, MarketBeat.com reports. Six investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month price target […]
Baxter International Inc. (NYSE:BAX – Get Free Report) declared a quarterly dividend on Tuesday, November 14th, RTT News reports. Stockholders of record on Friday, December 1st will be paid a dividend of 0.29 per share by the medical instruments supplier on Tuesday, January 2nd. This represents a $1.16 annualized dividend and a dividend yield of […]
StockNews.com initiated coverage on shares of Baxter International (NYSE:BAX – Free Report) in a research note released on Thursday. The firm issued a hold rating on the medical instruments supplier’s stock. Several other equities analysts also recently issued reports on BAX. KeyCorp dropped their price target on shares of Baxter International from $53.00 to $51.00 […]
Baxter International (NYSE:BAX – Free Report) had its price target decreased by KeyCorp from $53.00 to $51.00 in a research report released on Monday, Benzinga reports. KeyCorp currently has an overweight rating on the medical instruments supplier’s stock. BAX has been the topic of a number of other research reports. StockNews.com assumed coverage on shares […]